Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A26704 | 19929783 | Curr Med Chem | Branched-chain amino acids and pigment epithelium-derived factor: novel therapeutic agents for hepatitis c virus-associated insulin resistance. | 2009 | Details |
| A26705 | 19926158 | Diabetes Res Clin Pract | Abnormal aortic elasticity in patients with liver steatosis. | 2009 | Details |
| A26708 | 19923096 | Orv Hetil | [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease]. | 2009 | Details |
| A26709 | 19921118 | Adv Ther | Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status. | 2009 | Details |
| A26717 | 19910932 | Am J Hypertens | Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study. | 2009 | Details |
| A26720 | 19900166 | Clin Sci (Lond) | Hypoxia and non-alcoholic fatty liver disease. | 2009 | Details |
| A26722 | 19897197 | Atherosclerosis | Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. | 2009 | Details |
| A26724 | 19892897 | Postgrad Med J | The metabolic syndrome: common origins of a multifactorial disorder. | 2009 | Details |
| A26725 | 19891587 | Scand J Gastroenterol | Protective effects of SP600125 in a diet-induced rat model of non-alcoholic steatohepatitis. | 2009 | Details |
| A26726 | 19891019 | World J Gastroenterol | Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis. | 2009 | Details |
| A26727 | 19890679 | Hepatol Int | Serum α-fetoprotein levels in liver steatosis. | 2009 | Details |
| A26728 | 19887498 | Hum Reprod | Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. | 2009 | Details |
| A26734 | 19880582 | Diabetes Care | Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis. | 2009 | Details |
| A26737 | 19875987 | Obesity (Silver Spring) | Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients. | 2009 | Details |
| A26738 | 21160968 | World J Hepatol | Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. | 2009 | Details |
| A26740 | 19861959 | Am J Gastroenterol | Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension. | 2009 | Details |
| A26741 | 19860210 | Rinsho Byori | [Diagnosis and therapy in NASH]. | 2009 | Details |
| A26747 | 19840251 | Liver Int | Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease. | 2009 | Details |
| A26750 | 19834957 | Cancer | Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. | 2009 | Details |
| A26753 | 19832698 | Clin Sci (Lond) | Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. | 2009 | Details |
| A26756 | 19799688 | J Gastroenterol Hepatol | The liver and the waistline: Fifty years of growth. | 2009 | Details |
| A26759 | 19820404 | Eur J Gastroenterol Hepatol | Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis? | 2010 | Details |
| A26768 | 19818304 | Clin Liver Dis | Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. | 2009 | Details |
| A26774 | 19813185 | Muscle Nerve | Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy. | 2010 | Details |
| A26775 | 19811343 | Scand J Gastroenterol | Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial. | 2009 | Details |
| A26776 | 19809879 | Rev Endocr Metab Disord | Identification and treatment of metabolic complications in pediatric obesity. | 2009 | Details |
| A26784 | 19788607 | J Gastroenterol Hepatol | Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis. | 2009 | Details |
| A26793 | 19777393 | Curr Opin Investig Drugs | Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. | 2009 | Details |
| A26794 | 19773396 | J Clin Endocrinol Metab | Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. | 2009 | Details |
| A26798 | 19765850 | J Hepatol | Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. | 2009 | Details |
| A26800 | 19761871 | Contemp Clin Trials | Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. | 2009 | Details |
| A26804 | 19751410 | Ann N Y Acad Sci | From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis. | 2009 | Details |
| A26809 | 19740705 | Clin Immunol | The role of resistin as a regulator of inflammation: Implications for various human pathologies. | 2009 | Details |
| A26812 | 19733470 | J Nutr Biochem | Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis. | 2009 | Details |
| A26813 | 19731869 | Vnitr Lek | [Metabolic syndrome and the liver (NAFLD/NASH)]. | 2009 | Details |
| A26814 | 19731235 | Hepatology | Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice. | 2009 | Details |
| A26815 | 19730384 | Eur J Gastroenterol Hepatol | Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. | 2010 | Details |
| A26816 | 19728847 | Clin Chem Lab Med | A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients. | 2009 | Details |
| A26818 | 19727004 | J Clin Gastroenterol | Effect of weight loss on nonalcoholic fatty liver disease. | 2010 | Details |
| A26820 | 19724016 | Am J Physiol Endocrinol Metab | Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. | 2009 | Details |
| A26821 | 19720629 | J Clin Pathol | Werner syndrome as a possible cause of non-alcoholic steatohepatitis. | 2009 | Details |
| A26826 | 19702910 | J Gastroenterol Hepatol | Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. | 2009 | Details |
| A26828 | 19702660 | J Med Primatol | Association of monocyte chemoattractant protein-1 with adipocyte number, insulin resistance and liver function markers. | 2009 | Details |
| A26829 | 19697129 | Dig Dis Sci | Clinical and histological features of nonalcoholic fatty liver disease in children. | 2009 | Details |
| A26830 | 19693638 | Obes Surg | Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery. | 2009 | Details |
| A26831 | 19691668 | Aliment Pharmacol Ther | Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease. | 2009 | Details |
| A26832 | 19690397 | Gerontology | Non-alcoholic fatty liver disease in older people. | 2009 | Details |
| A26844 | 19667999 | Eur J Gastroenterol Hepatol | Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease. | 2010 | Details |
| A26848 | 19664840 | J Hepatol | Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. | 2009 | Details |
| A26851 | 19652102 | Arch Pediatr Adolesc Med | Onset of puberty and cardiovascular risk factors in untreated obese children and adolescents: a 1-year follow-up study. | 2009 | Details |
| A26856 | 19637776 | Acta Gastroenterol Belg | Tumor necrosis factor--alpha gene promoter polymorphisms in Chinese patients with nonalcoholic fatty liver diseases. | 2009 | Details |
| A26857 | 19637730 | Rev Invest Clin | [Pathophysiology of non-alcoholic steatohepatitis. An insulin resistance overview]. | 2009 | Details |
| A26859 | 19637282 | Hepatology | Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. | 2009 | Details |
| A26865 | 19624771 | Hepatol Res | Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease. | 2009 | Details |
| A26873 | 19604596 | J Hepatol | Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. | 2009 | Details |
| A26875 | 19602132 | Liver Int | Liver fat and lipid oxidation in humans. | 2009 | Details |
| A26880 | 19592219 | Nutrition | Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect? | 2009 | Details |
| A26887 | 19584882 | Obesity (Silver Spring) | Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort. | 2009 | Details |
| A26891 | 19575599 | Annu Rev Nutr | Nonalcoholic fatty liver disease and low-carbohydrate diets. | 2009 | Details |
| A26894 | 19573457 | Zhonghua Er Ke Za Zhi | [Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children]. | 2009 | Details |
| A26897 | 19568858 | Environ Health Prev Med | Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. | 2009 | Details |
| A26910 | 19554810 | J Pediatr Endocrinol Metab | Can the insulin sensitivity index (ISI) in association with insulin-like growth factor binding protein-1 identify insulin resistance early in overweight children? | 2009 | Details |
| A26917 | 19381120 | Ann Hepatol | Metabolic syndrome and non-alcoholic fatty liver disease. | 2009 | Details |
| A26918 | 19381119 | Ann Hepatol | New insights into the pathophysiology of nonalcoholic fatty liver disease. | 2009 | Details |
| A26923 | 19542757 | J Endocrinol Invest | Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome. | 2009 | Details |
| A26930 | 19525862 | J Clin Gastroenterol | Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD. | 2009 | Details |
| A26931 | 19525859 | J Clin Gastroenterol | Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26934 | 19519467 | Endocr Metab Immune Disord Drug Targets | Dissecting insulin signaling pathways: individualised therapeutic targets for diagnosis and treatment of insulin resistant states. | 2009 | Details |
| A26935 | 19519352 | Curr Drug Targets | Liver fibrosis and therapeutic strategies: the goal for improving metabolism. | 2009 | Details |
| A26938 | 19513842 | Dig Dis Sci | Insulin resistance is common in patients with predominantly genotype 3 chronic hepatitis C. | 2009 | Details |
| A26939 | 19513120 | PLoS One | Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. | 2009 | Details |
| A26941 | 19502653 | Ann Hepatol | Common SPINK-1 mutations do not predispose to the development of non-alcoholic fatty liver disease. | 2009 | Details |
| A26943 | 19502161 | Hepatobiliary Pancreat Dis Int | Commonly used animal models of non-alcoholic steatohepatitis. | 2009 | Details |
| A26945 | 19491421 | Indian J Med Res | A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease. | 2009 | Details |
| A26946 | 19490416 | Liver Int | Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice. | 2009 | Details |
| A26947 | 19484180 | J Gastroenterol | Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. | 2009 | Details |
| A26948 | 19478676 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems. | 2010 | Details |
| A26949 | 19476560 | J Gastroenterol Hepatol | Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. | 2009 | Details |
| A26950 | 19475694 | Hepatology | Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. | 2009 | Details |
| A26951 | 19474742 | Eur J Gastroenterol Hepatol | Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance. | 2009 | Details |
| A26955 | 19466213 | Arq Bras Endocrinol Metabol | Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. | 2009 | Details |
| A26957 | 19464851 | Epilepsy Res | Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment. | 2009 | Details |
| A26959 | 19464069 | J Hepatol | Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. | 2009 | Details |
| A26960 | 19460054 | Intern Med J | Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes. | 2010 | Details |
| A26961 | 19459046 | Dig Dis Sci | Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. | 2009 | Details |
| A26962 | 19452573 | World J Gastroenterol | Signal transduction mechanism of TRB3 in rats with non-alcoholic fatty liver disease. | 2009 | Details |
| A26966 | 19447517 | J Hepatol | Kupffer cells in non-alcoholic fatty liver disease: the emerging view. | 2009 | Details |
| A26968 | 19444865 | Diabetes Metab Res Rev | Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload. | 2009 | Details |
| A26969 | 19444112 | Curr Opin Pediatr | The metabolic syndrome and nonalcoholic fatty liver disease in children. | 2009 | Details |
| A26972 | 19440836 | Dig Dis Sci | Levels of soluble CD40 ligand and P-Selectin in nonalcoholic fatty liver disease. | 2009 | Details |
| A26976 | 19424408 | Rev Gastroenterol Peru | [Non alcoholic fatty liver. A frequent entity with an unknown outcome]. | 2009 | Details |
| A26977 | 19423319 | J Nutr Biochem | Mukitake mushroom (Panellus serotinus) alleviates nonalcoholic fatty liver disease through the suppression of monocyte chemoattractant protein 1 production in db/db mice. | 2009 | Details |
| A26978 | 19422483 | Liver Int | Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. | 2009 | Details |
| A26982 | 19413701 | Obes Rev | Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers. | 2009 | Details |
| A26985 | 19409898 | Gastroenterology | Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. | 2009 | Details |
| A26987 | 19408737 | Acta Gastroenterol Latinoam | [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?]. | 2009 | Details |
| A26988 | 19403348 | Dig Liver Dis | Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis. | 2009 | Details |
| A26989 | 19396962 | Curr Opin Gastroenterol | Recent advances in nonalcoholic fatty liver disease. | 2009 | Details |
| A26991 | 19390517 | Obesity (Silver Spring) | Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. | 2009 | Details |
| A26992 | 19387108 | J Alzheimers Dis | Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. | 2009 | Details |